Table 1.
Summary of pseudonymous cases with respect to histological characteristics.
| Characteristic | Absolute Number | Percentage (%) | |
|---|---|---|---|
| Cases | 38 | 100 | |
| CANCER SUBTYPE 1 | AC | 6 | 15.8 |
| TC | 14 | 36.8 | |
| LCNEC | 10 | 26.3 | |
| SCLC | 8 | 21.1 | |
| LOCATION 2 | ML | 5 | 13.2 |
| LU | 13 | 34.2 | |
| RU | 4 | 10.5 | |
| LL | 8 | 21.1 | |
| RL | 8 | 21.1 | |
| HISTOLOGICAL GRADING (G) | G1 | 14 | 36.8 |
| G2 | 6 | 15.8 | |
| G3 | 18 | 47.4 | |
| TUMOR (T) STAGE | T1a | 15 | 39.5 |
| T1b | 7 | 18.4 | |
| T2a | 7 | 18.4 | |
| T2b | 1 | 2.6 | |
| pT3 | 7 | 18.4 | |
| n.a. 3 | 1 | 2.6 | |
| NODAL (N) STAGE | N0 | 27 | 71.1 |
| N1 | 5 | 13.2 | |
| N2 | 3 | 7.9 | |
| N3 | 2 | 5.3 | |
| n.a. | 1 | 2.6 |
1 AC = atypical carcinoid; TC = typical carcinoid; LCNEC = large cell neuroendocrine tumor; SCLC = small cell lung cancer; 2 ML = middle lobe; LU = left upper lobe; LL = left lower lobe; RU = right upper lobe; RL = right lower lobe; 3 n.a. = not available.